Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
By K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörälä, U. Keil. The Lancet, 2009
870 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health, Surgery
View Paper: https://www.semanticscholar.org/paper/102bd9899a4168cced9b9b2b0819c6353a6f08ef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Surgery
Citations in the corpus
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “Too much guidance and too little impact? The gap between state-of-the-art knowledge and its implementation in clinical practice remains wide, as shown in recent surveys such as EUROASPIRE III.(5) Family doctors may be flooded with recommendations in the wide field of family medicine.”
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Despite overwhelming evidence that hypertension is a major CV risk factor and that BP-lowering strategies substantially reduce the risk, studies performed outside Europe and in several European countries [16,683] consistently show that (i) a noticeable proportion of hypertensive individuals are unaw”
- Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations (2013, background): “The increasing mortality in some countries in Eastern Europe is likely to re fl ect a combination of continued high exposure to cardio-vascular risk factors (including tobacco smoke [32]) and inadequate prevention strategies e.g. poor control of hypertension [33,34].”
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “and BP control is improving slowly or not at all—and this is the case also in secondary prevention.(699,700) Because, in clinical trials, antihypertensive treatment can achieve BP control in the majority of the patients,(701) these data reflect the wide gap that exists”